XDEMVY (lotilaner ophthalmic solution) 0.25%, formerly known as TP-03, is a novel prescription eye drop designed to treat Demodex blepharitis by targeting and eradicating the root cause of the disease ...
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert ...
A doctor has issued a warning over a parasitic eye infection that is caused by a common thing millions of people do. There are plenty of things millions of people do every day that have the potential ...
But what about pore cleaning mites like Demodex folliculorum that spend their entire life living deep in our faces? At night, the 0.3mm long organisms leave the pores to find a new skin follicle ...
It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company’s lead candidate TP-03, is a novel drug that ...
"Treatment with topical ivermectin may improve the symptoms of rosacea through modulation of the skin microbiome beyond decreasing Demodex," the authors concluded. "The results of this study,” they ...